Phase I clinical trial assessing AC003
Latest Information Update: 05 Mar 2025
Price :
$35 *
At a glance
- Drugs AC 003 (Primary)
- Indications Graft-versus-host disease
- Focus Adverse reactions
- 05 Mar 2025 New trial record
Latest Information Update: 05 Mar 2025